Literature DB >> 24863246

From biomarker development towards implementation of multidimensional biomarker panels in a clinical setting.

Léon C van Kempen1, Alan Spatz2.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24863246      PMCID: PMC5528538          DOI: 10.1016/j.molonc.2014.05.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  6 in total

1.  From biomarker development towards implementation of multidimensional biomarker panels in a clinical setting.

Authors:  Léon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2014-05-14       Impact factor: 6.603

2.  Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

Authors:  Lale Erdem-Eraslan; Lonneke A Gravendeel; Johan de Rooi; Paul H C Eilers; Ahmed Idbaih; Wim G M Spliet; Wilfred F A den Dunnen; Johannes L Teepen; Pieter Wesseling; Peter A E Sillevis Smitt; Johan M Kros; Thierry Gorlia; Martin J van den Bent; Pim J French
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

3.  Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types.

Authors:  Paolo A Ascierto; Michael Kalos; David A Schaer; Margaret K Callahan; Jedd D Wolchok
Journal:  Clin Cancer Res       Date:  2013-03-01       Impact factor: 12.531

4.  Evaluating many treatments and biomarkers in oncology: a new design.

Authors:  Richard Kaplan; Timothy Maughan; Angela Crook; David Fisher; Richard Wilson; Louise Brown; Mahesh Parmar
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

5.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

6.  KIT oncogene inhibition drives intratumoral macrophage M2 polarization.

Authors:  Michael J Cavnar; Shan Zeng; Teresa S Kim; Eric C Sorenson; Lee M Ocuin; Vinod P Balachandran; Adrian M Seifert; Jonathan B Greer; Rachel Popow; Megan H Crawley; Noah A Cohen; Benjamin L Green; Ferdinand Rossi; Peter Besmer; Cristina R Antonescu; Ronald P DeMatteo
Journal:  J Exp Med       Date:  2013-12-09       Impact factor: 14.307

  6 in total
  1 in total

1.  From biomarker development towards implementation of multidimensional biomarker panels in a clinical setting.

Authors:  Léon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2014-05-14       Impact factor: 6.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.